82 related articles for article (PubMed ID: 1436288)
1. Lipids in the progression of chronic renal failure.
Cappelli P; Evangelista M; Bonomini M; Palmieri PF; Albertazzi A
Nephron; 1992; 62(1):31-5. PubMed ID: 1436288
[TBL] [Abstract][Full Text] [Related]
2. Role of dyslipidemia in the progression of chronic renal disease.
Cappelli P; Di Liberato L; Albertazzi A
Ren Fail; 1998 Mar; 20(2):391-7. PubMed ID: 9574467
[TBL] [Abstract][Full Text] [Related]
3. Residual renal function affects lipid profile in patients undergoing continuous ambulatory peritoneal dialysis.
Kagan A; Elimalech E; Lemer Z; Fink A; Bar-Khayim Y
Perit Dial Int; 1997; 17(3):243-9. PubMed ID: 9237284
[TBL] [Abstract][Full Text] [Related]
4. N-3 polyunsaturated fatty acid supplementation in chronic progressive renal disease.
Cappelli P; Di Liberato L; Stuard S; Ballone E; Albertazzi A
J Nephrol; 1997; 10(3):157-62. PubMed ID: 9238624
[TBL] [Abstract][Full Text] [Related]
5. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
6. Normal and gestational diabetic pregnancies. Lipids, lipoproteins and apolipoproteins.
de Arcos F; Castelo-Branco C; Casals E; Sanllehy C; Cararach V
J Reprod Med; 1998 Feb; 43(2):144-8. PubMed ID: 9513877
[TBL] [Abstract][Full Text] [Related]
7. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
[TBL] [Abstract][Full Text] [Related]
8. Comparison of lipid abnormalities in continuous ambulatory peritoneal dialysis and hemodialysis patients.
Ong-Ajyooth L; Sirisalee K; Shayakul C; Vareesangthip K; Vasuvattakul S; Vanichakarn S; Nimmannit S; Chirawong P; Ong-Ajyooth S; Nilwarangkur S
Transplant Proc; 1994 Aug; 26(4):2077-9. PubMed ID: 8066677
[No Abstract] [Full Text] [Related]
9. Evaluation of lipids, lipoproteins and apolipoproteins concentrations in cord blood serum of newborns from rural and urban environments.
Pac-Kozuchowska E
Ann Agric Environ Med; 2007; 14(1):25-9. PubMed ID: 17655173
[TBL] [Abstract][Full Text] [Related]
10. Decreases in apolipoprotein(a) after renal transplantation: implications for lipoprotein(a) metabolism.
Black IW; Wilcken DE
Clin Chem; 1992 Mar; 38(3):353-7. PubMed ID: 1547551
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E polymorphism and renal function in German type 1 and type 2 diabetic patients.
Werle E; Fiehn W; Hasslacher C
Diabetes Care; 1998 Jun; 21(6):994-8. PubMed ID: 9614620
[TBL] [Abstract][Full Text] [Related]
12. Lipids and apolipoproteins change during the progression of chronic renal failure.
Bergesio F; Monzani G; Ciuti R; Serruto A; Benucci A; Frizzi V; Salvadori M
Clin Nephrol; 1992 Nov; 38(5):264-70. PubMed ID: 1451339
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of lipid parameters and bioindices in patients with different stages of chronic renal failure.
Cabarkapa V; Djerić M; Stosić Z; Sakac V; Zagorka LC; Vucković B
Vojnosanit Pregl; 2012 Nov; 69(11):961-6. PubMed ID: 23311247
[TBL] [Abstract][Full Text] [Related]
14. Renal function and lipid metabolism in pregnant renal transplant recipients.
Czajkowski K; Wójcicka-Bentyn J; Sieńko J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E
Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):155-61. PubMed ID: 15140508
[TBL] [Abstract][Full Text] [Related]
15. Lipid and apolipoproteins (ApoAI, ApoB, Apo CIII, ApoE) disturbance in hemodialysis (HD) and renal transplant (Tx) patients.
Janicki K; Solski J; Janicka L; Kimak E; Bednarek-Skublewska A; Stettner S; Molas G
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):459-66. PubMed ID: 16146031
[TBL] [Abstract][Full Text] [Related]
16. [Change in the spectrum of lipids and apoproteins A1 and B as affected by hypothiazide and pratsiol in patients with hypertension].
Oganov RG; Mustafaev II; Perova NV; Postol'nikov SF; Metel'skaia VA
Kardiologiia; 1985 Aug; 25(8):17-22. PubMed ID: 4068453
[TBL] [Abstract][Full Text] [Related]
17. Effect of protein-reduced diet on plasma lipids, apolipoproteins and lipolytic activities in patients with chronic renal failure.
Attman PO; Gustafson A; Alaupovic P; Wang CS
Am J Nephrol; 1984; 4(2):92-8. PubMed ID: 6586074
[TBL] [Abstract][Full Text] [Related]
18. Short-term effects of renal transplantation on plasma lipids and lipoprotein lipase in children with congenital nephrosis.
Antikainen M; Holmberg C; Taskinen MR
Clin Nephrol; 1994 May; 41(5):284-9. PubMed ID: 8050208
[TBL] [Abstract][Full Text] [Related]
19. Are lipoprotein disturbances in chronic hemodialyzed patients only renal failure related?
Jakić M; Lovcić V; Klarić D; Mihaljević D; Zibar L; Jakić M; Marić I
Coll Antropol; 2010 Mar; 34 Suppl 1():181-8. PubMed ID: 20402316
[TBL] [Abstract][Full Text] [Related]
20. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis.
Attman PO; Alaupovic P
Nephron; 1991; 57(4):401-10. PubMed ID: 2046821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
